Listar por agencia financiadora "Celgene"
Mostrando ítems 1-1 de 1
-
Artículo
Efficacy of bortezomib to intensify the conditioning regimen and the graft-versus-host disease prophylaxis for high-risk myeloma patients undergoing transplantation
(Springer Nature, 2020)This multicenter phase I trial was designed to evaluate the safety and efficacy of bortezomib (Bz) as part of both the ...